Page last updated: 2024-09-02

6-phenylhexyl isothiocyanate and Leukemia

6-phenylhexyl isothiocyanate has been researched along with Leukemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiao, JW; Hong, L; Huang, Y; Ma, X; Zou, Y1
Ahmed, T; Beklemishev, A; Chiao, JW; Liu, D; Lu, L; Ma, X; Seiter, K1

Other Studies

2 other study(ies) available for 6-phenylhexyl isothiocyanate and Leukemia

ArticleYear
Effect of phenylhexyl isothiocyanate on aberrant histone H3 methylation in primary human acute leukemia.
    Journal of hematology & oncology, 2012, Jul-02, Volume: 5

    Topics: Acetylation; Acute Disease; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Azacitidine; Case-Control Studies; Child; Decitabine; DNA Methylation; Female; Histone Deacetylase Inhibitors; Histone-Lysine N-Methyltransferase; Histones; Humans; Hydroxamic Acids; Isothiocyanates; Leukemia; Male; Middle Aged; Protein Processing, Post-Translational; Young Adult

2012
The phenylhexyl isothiocyanate induces apoptosis and inhibits leukemia cell growth in vivo.
    Oncology reports, 2006, Volume: 16, Issue:6

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor Proteins; Cyclins; Humans; Isothiocyanates; Leukemia; Male; Maximum Tolerated Dose; Mice; Mice, Nude; Neoplasm Transplantation; Phosphorylation; Retinoblastoma Protein

2006